Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
May 30, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-156011.pdf 0001193125-23-156011.rtf 0001193125-23-156011.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 25, 2023	8-K	Report of unscheduled material events or corporate event	0001628280-23-019654.pdf 0001628280-23-019654.rtf 0001628280-23-019654.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 25, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000004.pdf 0001517022-23-000004.rtf 0001517022-23-000004.xls View HTML
May 25, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000005.pdf 0001517022-23-000005.rtf 0001517022-23-000005.xls View HTML
May 25, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-004503.pdf 0001562180-23-004503.rtf 0001562180-23-004503.xls View HTML
May 25, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-004504.pdf 0001562180-23-004504.rtf 0001562180-23-004504.xls View HTML
May 23, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-151132.pdf 0001193125-23-151132.rtf 0001193125-23-151132.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 18, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-004253.pdf 0001562180-23-004253.rtf 0001562180-23-004253.xls View HTML
May 18, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-004254.pdf 0001562180-23-004254.rtf 0001562180-23-004254.xls View HTML
May 16, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-004168.pdf 0001562180-23-004168.rtf 0001562180-23-004168.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax